4.7 Article

Pathophysiology of spasticity in stroke

期刊

NEUROLOGY
卷 80, 期 -, 页码 S20-S26

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31827624a7

关键词

-

资金

  1. NHMRC
  2. Sydney Foundation for Medical Research
  3. Philip Bushell Foundation
  4. Brain Foundation
  5. Allergan, Inc.
  6. Merz Pharmaceuticals
  7. Medtronic
  8. Ipsen Pharma
  9. Allergan
  10. Boehringer Ingelheim
  11. Bayer
  12. Sanofi
  13. Florey Neuroscience Institutes through the Victorian Government Operational Infrastructure Scheme

向作者/读者索取更多资源

Spasticity is defined clinically by increased muscle tone and tendon jerk hyperreflexia in patients who are at rest. However, the excitability of spinal circuits changes during movement, and this definition provides no insight into the extent to which spasticity and associated motor disturbances cause disability. Only a few spinal circuits have been shown to underlie the abnormalities of patients at rest. Movement can be restrained by pathologically enhanced muscle tone, and there is defective control of the feedback to active motoneurons through virtually all spinal reflex pathways. Spasticity does not necessarily require treatment: in fact, some patients rely on the increased muscle tone to help support otherwise weak muscle contractions for stance and locomotion. In addition, much of the increase in muscle tone arises from changes in muscle and motor units, independent of reflex mechanisms. Managing a patient with impairment after a stroke requires therapy tailored to that particular patient because the mechanisms contributing to the disability experienced by one patient may differ from those affecting another. Neurology (R) 2013;80(Suppl 2):S20-S26

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Clinical Neurology

New publisher, new-year, new decade

Geoffrey A. Donnan

INTERNATIONAL JOURNAL OF STROKE (2016)

Article Clinical Neurology

Association between baseline peri-infarct magnetic resonance spectroscopy and regional white matter atrophy after stroke

Nawaf Yassi, Bruce C. V. Campbell, Bradford A. Moffat, Christopher Steward, Leonid Churilov, Mark W. Parsons, Geoffrey A. Donnan, Patricia M. Desmond, Stephen M. Davis, Andrew Bivard

NEURORADIOLOGY (2016)

Article Clinical Neurology

Positron Emission Tomographic Imaging in Stroke Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke

Ramesh Sahathevan, Thomas Linden, Victor L. Villemagne, Leonid Churilov, John V. Ly, Christopher Rowe, Geoffrey Donnan, Amy Brodtmann

STROKE (2016)

Article Clinical Neurology

European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND

Hemasse Amiri, Erich Bluhmki, Martin Bendszus, Christoph C. Eschenfelder, Geoffrey A. Donnan, Didier Leys, Carlos Molina, Peter A. Ringleb, Peter D. Schellinger, Stefan Schwab, Danilo Toni, Nils Wahlgren, Werner Hacke

INTERNATIONAL JOURNAL OF STROKE (2016)

Editorial Material Clinical Neurology

The crux of stroke management is still prevention

Geoffrey A. Donnan

INTERNATIONAL JOURNAL OF STROKE (2016)

Article Clinical Neurology

Identification of imaging selection patterns in acute ischemic stroke patients and the influence on treatment and clinical trial enrollment decision making

Marie Luby, Steven J. Warach, Gregory W. Albers, Jean-Claude Baron, Christophe Cognard, Antoni Davalos, Geoffrey A. Donnan, Jochen B. Fiebach, Jens Fiehler, Werner Hacke, Maarten G. Lansberg, David S. Liebeskind, Heinrich P. Mattle, Catherine Oppenheim, Peter D. Schellinger, Joanna M. Wardlaw, Max Wintermark

INTERNATIONAL JOURNAL OF STROKE (2016)

Editorial Material Clinical Neurology

Women in stroke, and cardiac devices in stroke management

Geoffrey A. Donnan

INTERNATIONAL JOURNAL OF STROKE (2016)

Editorial Material Clinical Neurology

NeuroRehabilitation

Geoffrey A. Donnan

INTERNATIONAL JOURNAL OF STROKE (2016)

Article Cardiac & Cardiovascular Systems

Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events

H. Y. Lim, C. Ng, G. Donnan, H. Nandurkar, Prahlad Ho

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)

Article Medicine, General & Internal

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

Mayank Goyal, Bijoy K. Menon, Wim H. van Zwam, Diederik W. J. Dippel, Peter J. Mitchell, Andrew M. Demchuk, Antoni Davalos, Charles B. L. M. Majoie, Aad van der Lugt, Maria A. de Miquel, Geoff Rey A. Donnan, Yvo B. W. E. M. Roos, Alain Bonafe, Reza Jahan, Hans-Christoph Diener, Lucie A. van den Berg, Elad I. Levy, Olvert A. Berkhemer, Vitor M. Pereira, Jeremy Rempel, Monica Millan, Stephen M. Davis, Daniel Roy, John Thornton, Luis San Roman, Marc Ribo, Debbie Beumer, Bruce Stouch, Scott Brown, Bruce C. V. Campbell, Robert J. van Oostenbrugge, Jeff Rey L. Saver, Michael D. Hill, Tudor G. Jovin

LANCET (2016)

Article Medicine, General & Internal

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon, Raul G. Nogueira, Ryan A. McTaggart, Andrew M. Demchuk, Alexandre Y. Poppe, Brian H. Buck, Thalia S. Field, Dar Dowlatshahi, Brian A. van Adel, Richard H. Swartz, Ruchir A. Shah, Eric Sauvageau, Charlotte Zerna, Johanna M. Ospel, Manish Joshi, Mohammed A. Almekhlafi, Karla J. Ryckborst, Mark W. Lowerison, Kathy Heard, David Garman, Diogo Haussen, Shawna M. Cutting, Shelagh B. Coutts, Daniel Roy, Jeremy L. Rempel, Axel C. R. Rohr, Daniela Lancu, Demetrios J. Sahlas, Amy Y. X. Yu, Thomas G. Devlin, Ricardo A. Hanel, Volker Puetz, Frank L. Silver, Bruce C. Campbell, Rene Chapot, Jeanne Teitelbaum, Jennifer L. Mandzia, Timothy J. Kleinig, David Turkel-Parrella, Donald Heck, Michael E. Kelly, Aditya Bharatha, Oh Young Bang, Ashutosh Jadhav, Rishi Gupta, Donald F. Frei, Jason W. Tarpley, Cameron G. McDougall, Staffan Holman, Joung-Ho Rha, Ajit S. Puri, Marie-Christine Camden, Gotz Thomalla, Hana Choe, Stephen J. Phillips, Joseph L. Schindler, John Thornton, Simon Nagel, Ji Hoe Heo, Sung- Sohn, Marios-Nikos Psychogios, Ronald F. Budzik, Sidney Starkman, Coleman O. Martin, Paul A. Burns, Sean Murphy, George A. Lopez, Joey English, Michael Tymianski

LANCET (2020)

Article Geriatrics & Gerontology

Prediction of disability-free survival in healthy older people

Johannes Tobias Neumann, Le T. P. Thao, Anne M. Murray, Emily Callander, Prudence R. Carr, Mark R. Nelson, Rory Wolfe, Robyn L. Woods, Christopher M. Reid, Raj C. Shah, Anne B. Newman, Jeff D. Williamson, Andrew M. Tonkin, John J. McNeil

Summary: This study analyzed data from ASPREE and found that age, cognitive function, and gait speed were the strongest predictors of disability-free survival in healthy older people. Other factors, such as body mass index and smoking status, were also associated with a worse prognosis.

GEROSCIENCE (2022)

Article Clinical Neurology

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke A Post Hoc Analysis of the EXTEND-IA TNK Trials

Vignan J. Yogendrakumar, Leonid J. Churilov, Peter Mitchell, Timothy Kleinig, Nawaf Yassi, Vincent Thijs, Teddy Wu, Darshan M. Shah, Peter Bailey, Helen Dewey, Philip M. C. Choi, Alice Ma, Tissa Wijeratne, Carlos V. Garcia-Esperon, Geoffrey J. Cloud, Ronil Chandra, Dennis Cordato, Bernard M. Yan, Gagan W. Sharma, Patricia A. Desmond, Mark M. Parsons, Geoffrey Donnan, Stephen Davis, Bruce C. V. Campbell, EXTEND IA TNK Investigators

Summary: This study compared the safety and efficacy of tenecteplase and alteplase in patients with tandem lesion stroke. The results showed that both drugs had similar effects on intracranial reperfusion and 90-day modified Rankin scale. Further research is needed to determine clinically important differences.

NEUROLOGY (2023)

Article Health Care Sciences & Services

Sustaining a New Model of Acute Stroke Care: A Mixed- Method Process Evaluation of the Melbourne Mobile Stroke Unit

Kathleen L. Bagot, Tara Purvis, Shaun Hancock, Henry Zhao, Skye Coote, Damien Easton, Bruce C. Campbell, Stephen M. Davis, Geoff A. Donnan, Shane Foster, Francesca Langenberg, Karen Smith, Michael Stephenson, Stephen Bernard, Sharon McGowan, Bernard Yan, Peter Mitchell, Sandy Middleton, Dominique A. Cadilhac

Summary: This study aimed to investigate the factors influencing the sustainability of the Mobile Stroke Unit (MSU) model. The findings suggest that cohesive teamwork, effective communication, and identified benefits are crucial for ensuring the sustainability of this innovative model.

INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2023)

Article Clinical Neurology

Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke

Julie Bernhardt, Karen Borschmann, Janice M. Collier, Amanda G. Thrift, Peter Langhorne, Sandy Middleton, Richard I. Lindley, Helen M. Dewey, Philip Bath, Catherine M. Said, Leonid Churilov, Fiona Ellery, Christopher Bladin, Christopher M. Reid, Judith H. Frayne, Velandai Srikanth, Stephen J. Read, Geoffrey A. Donnan

Summary: This tertiary analysis from the AVERT trial found that very early mobilization (VEM) poststroke increases mortality at 14 days when compared to usual care (UC), with a higher rate of stroke progression in the VEM group. There were no significant differences in nonfatal serious adverse events between the VEM and UC groups.

NEUROLOGY (2021)

暂无数据